The efficacy and safety of botulinum toxin type B on digital ulcers in patients with systemic sclerosis
Not Applicable
- Conditions
- digital ulcers in systemic sclerosis patients
- Registration Number
- JPRN-UMIN000024818
- Lead Sponsor
- Gunma University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients under the age 18, with the pregnancy or having the past medical histories with BTX were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of the patients which digital ulcer was healed by BTX-B at 8 weeks after treatment compared with that treated with placebo control.
- Secondary Outcome Measures
Name Time Method